Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Advertise
  • SUBSCRIBE

Catalent Expands Optimelt Hot Melt Extrusion to Improve Bioavailability

By Pharmaceutical Processing | September 26, 2013

Catalent Pharma Solutions, a leader in drug development solutions and advanced delivery technologies for pharmaceutical, biologic and consumer health products, today announced several advancements and expansion of its OptiMelt™ Hot Melt Extrusion (HME) capabilities in Somerset, NJ. Catalent’s OptiMelt technology is designed to help innovators overcome bioavailability challenges and create optimal delivery profiles and better dose forms.

The company announced that results from over 10 feasibility studies for customers utilizing OptiMelt technology have demonstrated its bioavailability enhancing capabilities. These programs were conducted across various therapeutic areas and stages of development, with several advancing to further development scale, which will ultimately result in better treatments for patients given eventual regulatory product approvals. 

To create an end-to-end capability, Catalent announced the addition of a commercial scale extruder at its Somerset facility, supplementing the development scale equipment already on site. This added investment will allow Catalent to continue to meet high customer demand for OptiMelt while also expanding its offerings to include lab, development, and commercial scale hot melt extrusion co-located with extensive final dose form technologies across its Somerset and Schorndorf, Germany facilities.

Commenting on the development milestone and capacity expansion, Barry Littlejohns, President of Catalent’s new Advanced Delivery Technologies business, said “Our OptiMelt HME platform has continued to strengthen in the last year as development partners have recognized the benefits of our technologies.  Our added commercial HME capacity will support customers’ projects as they transition to later phase clinical development and commercial supply, and also new customers desiring commercial scale direct tech transfers to our Somerset, NJ facility.”

Catalent’s integrated OptiMelt platform combines development and scale-up of HME technology with leading expertise in oral controlled release formulation and final dose form development including tablets, capsules and granules, offering customers an integrated solution to the formulation and commercialization of poorly soluble drugs.

Related Articles Read More >

This is a photo of the Fujifilm Diosynth Biotechnologies plant under construction in Holly Springs, North Carolina.
Fujifilm, Regeneron ink $3B U.S. manufacturing agreement
This is the logo of Johnson & Johnson.
J&J breaks ground on $2B manufacturing facility in North Carolina
sherwin-williams-pharma-facility (1)
Sherwin-Williams expands flooring solutions for pharma facilities
PHARMAP 2025: Pharma leaders converge in Berlin for fifth anniversary summit
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Advertise
  • SUBSCRIBE